Rapid Micro Biosystems (RPID)

• Market cap: $99.1M
• 1 day: 0%
• 5 days: -4.33%
• 1 month: 18.45%
• 3 months: -12.72%
• 6 months: -52.84%
• Year to date: -36.62%
• 1 year: -54.15%
• 5 years: -90.17%
• 10 years: -90.7%
• Sector: Healthcare
• Industry: Medical Devices

About: Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Employees: 171